First Time Loading...

ABVC Biopharma Inc
NASDAQ:ABVC

Watchlist Manager
ABVC Biopharma Inc Logo
ABVC Biopharma Inc
NASDAQ:ABVC
Watchlist
Price: 1.48 USD 9.63% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

ABVC's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. [ Read More ]

The intrinsic value of one ABVC stock under the Base Case scenario is 0.13 USD. Compared to the current market price of 1.48 USD, ABVC Biopharma Inc is Overvalued by 91%.

Key Points:
ABVC Intrinsic Value
Base Case
0.13 USD
Overvaluation 91%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
ABVC Biopharma Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ABVC stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
ABVC Biopharma Inc

Provide an overview of the primary business activities
of ABVC Biopharma Inc.

What unique competitive advantages
does ABVC Biopharma Inc hold over its rivals?

What risks and challenges
does ABVC Biopharma Inc face in the near future?

Has there been any significant insider trading activity
in ABVC Biopharma Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for ABVC Biopharma Inc.

Provide P/S
for ABVC Biopharma Inc.

Provide P/E
for ABVC Biopharma Inc.

Provide P/OCF
for ABVC Biopharma Inc.

Provide P/FCFE
for ABVC Biopharma Inc.

Provide P/B
for ABVC Biopharma Inc.

Provide EV/S
for ABVC Biopharma Inc.

Provide EV/GP
for ABVC Biopharma Inc.

Provide EV/EBITDA
for ABVC Biopharma Inc.

Provide EV/EBIT
for ABVC Biopharma Inc.

Provide EV/OCF
for ABVC Biopharma Inc.

Provide EV/FCFF
for ABVC Biopharma Inc.

Provide EV/IC
for ABVC Biopharma Inc.

Show me price targets
for ABVC Biopharma Inc made by professional analysts.

What are the Revenue projections
for ABVC Biopharma Inc?

How accurate were the past Revenue estimates
for ABVC Biopharma Inc?

What are the Net Income projections
for ABVC Biopharma Inc?

How accurate were the past Net Income estimates
for ABVC Biopharma Inc?

What are the EPS projections
for ABVC Biopharma Inc?

How accurate were the past EPS estimates
for ABVC Biopharma Inc?

What are the EBIT projections
for ABVC Biopharma Inc?

How accurate were the past EBIT estimates
for ABVC Biopharma Inc?

Compare the revenue forecasts
for ABVC Biopharma Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of ABVC Biopharma Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of ABVC Biopharma Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of ABVC Biopharma Inc compared to its peers.

Compare the P/E ratios
of ABVC Biopharma Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing ABVC Biopharma Inc with its peers.

Analyze the financial leverage
of ABVC Biopharma Inc compared to its main competitors.

Show all profitability ratios
for ABVC Biopharma Inc.

Provide ROE
for ABVC Biopharma Inc.

Provide ROA
for ABVC Biopharma Inc.

Provide ROIC
for ABVC Biopharma Inc.

Provide ROCE
for ABVC Biopharma Inc.

Provide Gross Margin
for ABVC Biopharma Inc.

Provide Operating Margin
for ABVC Biopharma Inc.

Provide Net Margin
for ABVC Biopharma Inc.

Provide FCF Margin
for ABVC Biopharma Inc.

Show all solvency ratios
for ABVC Biopharma Inc.

Provide D/E Ratio
for ABVC Biopharma Inc.

Provide D/A Ratio
for ABVC Biopharma Inc.

Provide Interest Coverage Ratio
for ABVC Biopharma Inc.

Provide Altman Z-Score Ratio
for ABVC Biopharma Inc.

Provide Quick Ratio
for ABVC Biopharma Inc.

Provide Current Ratio
for ABVC Biopharma Inc.

Provide Cash Ratio
for ABVC Biopharma Inc.

What is the historical Revenue growth
over the last 5 years for ABVC Biopharma Inc?

What is the historical Net Income growth
over the last 5 years for ABVC Biopharma Inc?

What is the current Free Cash Flow
of ABVC Biopharma Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for ABVC Biopharma Inc.

Financials

Balance Sheet Decomposition
ABVC Biopharma Inc

Current Assets 1.7m
Cash & Short-Term Investments 139.5k
Receivables 759.6k
Other Current Assets 757.7k
Non-Current Assets 12.8m
Long-Term Investments 2.5m
PP&E 8.8m
Other Non-Current Assets 1.5m
Current Liabilities 5.9m
Accrued Liabilities 4.1m
Short-Term Debt 899.3k
Other Current Liabilities 935k
Non-Current Liabilities 172.1k
Other Non-Current Liabilities 172.1k
Efficiency

Earnings Waterfall
ABVC Biopharma Inc

Revenue
152.4k USD
Cost of Revenue
-302k USD
Gross Profit
-149.6k USD
Operating Expenses
-8.1m USD
Operating Income
-8.2m USD
Other Expenses
-2.3m USD
Net Income
-10.5m USD

Free Cash Flow Analysis
ABVC Biopharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

ABVC Profitability Score
Profitability Due Diligence

ABVC Biopharma Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

20/100
Profitability
Score

ABVC Biopharma Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

ABVC Solvency Score
Solvency Due Diligence

ABVC Biopharma Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Positive Net Debt
Short-Term Solvency
27/100
Solvency
Score

ABVC Biopharma Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ABVC Price Targets Summary
ABVC Biopharma Inc

Wall Street analysts forecast ABVC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABVC is 2.02 USD .

Lowest
Price Target
Not Available
Average
Price Target
2.02 USD
36% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

ABVC Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

ABVC Price
ABVC Biopharma Inc

1M 1M
+41%
6M 6M
+74%
1Y 1Y
-78%
3Y 3Y
-97%
5Y 5Y
-99%
10Y 10Y
-100%
Annual Price Range
1.48
52w Low
0.81
52w High
9.2
Price Metrics
Average Annual Return -48.23%
Standard Deviation of Annual Returns 39.16%
Max Drawdown -100%
Shares Statistics
Market Capitalization 15.6m USD
Shares Outstanding 10 560 400
Percentage of Shares Shorted 17.07%

ABVC Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

ABVC Biopharma Inc Logo
ABVC Biopharma Inc

Country

United States of America

Industry

N/A

Market Cap

15.6m USD

Dividend Yield

0%

Description

ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The company is headquartered in Fremont, California and currently employs 28 full-time employees. The company went IPO on 2004-11-09. The firm develops its pipeline by tracking medical discoveries or medical device technologies in research institutions in the Asia-Pacific region. Its pipeline includes ABV-1501, ABV-1504, ABV-1505, ABV-1703, ABV-1601, ABV-1701 and ABV-2002. ABV-1504 is a botanical reuptake inhibitor that targets norepinephrine to treat major depressive disorder (MDD). The company is developing ABV-1505 for treating attention deficit hyperactivity disorder (ADHD). The company has developed ABV-1601 for treating depression in cancer patients. ABV-1501 is a combination therapy for triple negative breast cancer (TNBC). ABV-1701 is a vitreous substitute for vitrectomy. ABV-1703 is a drug for advanced inoperable or metastatic pancreatic cancer. ABV-2002 is a corneal storage media consisting of a specific polymer formulated to protect ocular tissues from osmolarity.

Contact

CALIFORNIA
Fremont
44370 Old Warm Springs Blvd
+15106680881.0
https://abvcpharma.com/

IPO

2004-11-09

Employees

28

Officers

Chairman & Chief Business Officer
Mr. Eugene Jiang
Chief Executive Officer
Dr. Uttam Yashwant Patil Ph.D.
CFO & Principal Accounting Officer
Mr. Leeds Chow
Chief Scientific Officer, Chief Strategy Officer & Director
Dr. Tsung-Shann Jiang EMBA, Ph.D.

See Also

Discover More
What is the Intrinsic Value of one ABVC stock?

The intrinsic value of one ABVC stock under the Base Case scenario is 0.13 USD.

Is ABVC stock undervalued or overvalued?

Compared to the current market price of 1.48 USD, ABVC Biopharma Inc is Overvalued by 91%.